Contrasting Dosivent With Plus Flow Vu Spacer in Bronchial Hyperreactivity Participants
Bronchial Hyperreactivity, Inhalant Use
About this trial
This is an interventional diagnostic trial for Bronchial Hyperreactivity
Eligibility Criteria
Inclusion Criteria: Participants over 18 years of age Attending our center for a bronchodilator test Positive bronchodilator result with increase of Forced Expiratory Volume in first second greater than 200 mililiters and 12% Provided written informed consent for participation in this study Exclusion Criteria: Grade A quality spirometry was not obtained according to the classification in current regulation Performing a bronchodilator test, in the opinion of the investigator, could pose a risk to the participant or interrupting the usual bronchodilator treatment could worsen the underlying respiratory pathology.
Sites / Locations
- Hospital General Universitario Gregorio Marañon
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Aerochamber Plus® Flow-Vu®
Dosivent
1. Inhaled space chamber commonly use in our lung function lab for Bronchodilator Testing
2. Newer and different inhaled space chamber for Bronchodilator Testing